Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michele Guitton"'
Autor:
Valérie Steier, Catherine Seys, Maxime Lampilas, Claudine Dupuis-Hamelin, Carole Delachaume, Michele Guitton, Thérèse Stachyra, Alain Bonnefoy, Monique Fairley
Publikováno v:
Journal of Antimicrobial Chemotherapy. 54:410-417
OBJECTIVES Production of beta-lactamases is the main mechanism of beta-lactam resistance in Gram-negative bacteria. Despite the current use of clavulanic acid, sulbactam and tazobactam, the prevalence of class A and class C enzymes is increasing worl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1b4059cab97926e6d8314f4bc869e49
https://doi.org/10.1093/jac/dkh358
https://doi.org/10.1093/jac/dkh358
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:1688-1692
We compared the oral antibacterial activities of telithromycin (HMR 3647), a new ketolide drug, in different infections induced in mice by Staphylococcus aureus, Streptococcus pneumoniae , streptococci, enterococci, and Haemophilus influenzae with th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d5c835a022c13fd018512aaed305251
https://doi.org/10.1128/aac.45.6.1688-1692.2001
https://doi.org/10.1128/aac.45.6.1688-1692.2001
Publikováno v:
The Journal of antimicrobial chemotherapy. 48(1)
The in vitro activity of HMR 3562, a new 2-fluoro-ketolide drug, was investigated against 95 enterococci, including 36 vancomycin-resistant strains. HMR 3562 inhibited 90% of enterococci susceptible or resistant to erythromycin A at 0.005 and 0.6 mg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cd3b4521ea6630b91d249968754a19a
https://pubmed.ncbi.nlm.nih.gov/11418524
https://pubmed.ncbi.nlm.nih.gov/11418524